Anemia of Cancer: An Overview

Doll D.C. Weiss R.B. : Neoplasia and the erythron. J Clin Oncol, 3: 429–446, 1985.

Weinstein I.M. Rosenbloom B.E. : Hematologic problems in patients with cancer and chronic inflammatory disorders. In: Hematology. Basic principles and practice, Hoffman R. Beriz E.J. Shattil S.J. Furie B. Cohen H.J. Silberstein L.E. (Eds), pp 2144–2154, Churchill Livingstone, New York, 1995.

Montserrat E. Bosch F. Rozman C. : B-cell chronic lymphocytic leukemia: recent progress in biology, diagnosis, and therapy. Ann Oncol, 8(suppl 1): 93–101, 1997.

Heaney M.L. Golde D.W. : Myelodysplasia. N Engl J Med, 340: 1649–1660, 1999.

Ludwig H. Fritz E. : Anemia in cancer patients. Semin Oncol, 25(suppl 7): 2–6, 1998.

Jurado R.L. : Iron, infections, and anemia of inflammation. Clin Infect Dis, 25: 888–895, 1997.

Andrews N.C. : Disorders of iron metabolism. N Engl J Med, 341: 1986–1995, 1999.

Miller C.B. Jones R.J. Piantadosi S. Abeloff M.D. Spivak J.L. : Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med, 322: 1689–1692, 1990.

Means R.T. Jr. , Krantz S.B. : Progress in understanding the pathogenesis of the anemia of chronic disease. Blood, 80: 1639–1647, 1992.

Casadevall N. : Update on the role of epoietin alpha in hematologic malignancies and myelodysplastic syndromes. Semin Oncol, 25(suppl 7): 12–18, 1998.

Ludwig H. Fritz E. : Anemia of cancer patients: patient selection and patient stratification for epoietin treatment. Semin Oncol, 25(suppl 7): 35–38, 1998.

Beguin Y. : Prediction of response to optimize outcome of treatment with erythropoietin. Semin Oncol, 25(suppl 7): 27–34, 1998.

Cazzola M. Messinger D. Battistel V. Bron D. Cimino R. Enller-Ziegler L. Essers U. : Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response. Blood, 86: 4446–4453, 1995.

Sthoeger Z.M. Sthoeger D. Shtalrid M. Sigler E. Geltner D. Berrebi A. : Mechanism of autoimmune hemolytic anemia in chronic lymphocytic leukemia. Am J Hematol, 43: 259–264, 1993.

Efremov D.G. Ivanovski M. Siljanovski N. Pozzato G. Cevreska L. Fais F. Chiorazzi N. Batista F.D. Burrone O.R. : Restricted immunoglobulin VH region repertoire in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia. Blood, 87: 3869–3876, 1996.

Athens J.W. Ward J.H. : Complications of hematopoietic neoplasms. In: Wintrobe's clinical hematology, Lee GR , Bithell TC , Foerster J , Athens JW , Lukens JN (Eds), pp 1792–1842, Lea & Febiger, Philadelphia, 1993.

Kipps T.J. Carson D.A. : Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases. Blood, 81: 2475–2487, 1993.

Lacy M.Q. Kurtin P.J. Tefferi A. : Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities. Blood, 87: 3000–3006, 1996.

Charles R.J. Sabo K.M. Kidd P.G. Abkowitz J.L. : The pathophysiology of pure red cell aplasia: implications for therapy. Blood, 87: 4831–4838, 1996.

Glaspy J. Bukowski R. Steinberg D. Taylor C. Tchekmedyian S. Vadhan-Raj S. for the Procrit Study Group: Impact of therapy with epoietin alpha on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. J Clin Oncol, 15: 1218–1234, 1997.

Rose E. Rai K. Revicki D. Brown R. Reblando J. and the Epo in anemia of CLL Study Group: Clinical and health status assessments in anemic chronic lymphocytic leukemia (CLL) patients treated with epoietin alpha (EPO) (abstr no 2091). Blood, 84(suppl 1): 526a, 1994.

Osterborg A. Boogaerts M.A. Cimino R. Essers U. Holowiecki J. Juliusson G. Jager G. Najman A. Peest D. for the European Study Group of Erythropoietin (epoietin beta) Treatment in Multiple Myeloma and Non-Hodgking's Lymphomas: Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma. A randomized multicenter study. Blood, 87: 2675–2682, 1996.

Mittelman M. Zeidman A. Fradin Z. Magazanik A. Lewinski U.H. Cohen A. : Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia. Acta Haematol, 98: 204–210, 1997.

Rose E.H. Abels R.I. Nelson R.A. McCullough D.M. Lessin L. : The use of r-HuEpo in the treatment of anemia related to myelodysplasia (MDS). Br J Haematol, 89: 831–837, 1995.

Hellstrom-Lindberg E. : Efficacy of erythropoietin in the myelodysplastic syndromes: a meta-analysis of 205 patients from 17 studies. Br J Haematol, 89: 67–71, 1995.

Italian Cooperative Study Group for rHuEpo in Myelodysplastic Syndromes: A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes. Br J Haematol, 103: 1070–1074, 1998.